Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Articles

Suppression of Pituitary Tumor Growth and Function by Ergot Alkaloids

Robert M. MacLeod and Joyce E. Lehmeyer
Robert M. MacLeod
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joyce E. Lehmeyer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published April 1973
  • Article
  • Info & Metrics
  • PDF
Loading

Summary

The in vivo and in vitro effects of ergot derivatives on prolactin and growth hormone biosynthesis in the rat have been studied. Injection with 0.05 or 0.2 mg ergotamine tartrate had no effect on in vitro prolactin synthesis by the pituitary gland. Ergocornine and ergocryptine, however, inhibited both synthesis and release of prolactin. Incubation of glands with 4 or 40 µm ergotamine greatly decreased prolactin synthesis and release but had no effect on growth hormone. Ergocornine, 10 µm, and ergocryptine, 10 µm, almost completely blocked prolactin release and decreased synthesis and release of growth hormone as well.

Daily administration of 0.05 mg ergotamine for 13 days to rats bearing the prolactin- and adrenocorticotropic hormonesecreting pituitary Tumor 7315a dramatically inhibited tumor growth and reversed the adrenal hypertrophy caused by the tumor adrenocorticotropic hormone. Ergotamine, ergocryptine, and ergocornine were all effective in suppressing the growth of pituitary tumors and reversed the splenohepatomegalia caused by growth hormone-secreting tumors. In addition, the ergots decreased the high circulating prolactin levels found in tumor-bearing animals. Ergotamine alone was able to overcome the atrophy of the pituitary glands of tumor-bearing animals and allow gland function to return toward normal. Ergocryptine and ergocornine tended further to suppress gland function. These data demonstrate that hormone synthesis and release by the pituitary gland and pituitary tumors can be inhibited by derivatives of the ergot alkaloids.

Footnotes

  • ↵1 This investigation was supported by USPHS Grant CA-07535 from the National Cancer Institute.

  • ↵3 Investigation conducted while a recipient of Research Career Development Award CA-07665 from the National Cancer Institute.

  • Received September 5, 1972.
  • Accepted January 8, 1973.
  • ©1973 American Association for Cancer Research.
PreviousNext
Back to top
April 1973
Volume 33, Issue 4
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Suppression of Pituitary Tumor Growth and Function by Ergot Alkaloids
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Suppression of Pituitary Tumor Growth and Function by Ergot Alkaloids
Robert M. MacLeod and Joyce E. Lehmeyer
Cancer Res April 1 1973 (33) (4) 849-855;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Suppression of Pituitary Tumor Growth and Function by Ergot Alkaloids
Robert M. MacLeod and Joyce E. Lehmeyer
Cancer Res April 1 1973 (33) (4) 849-855;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • The Role of Chimeric Paired Box Transcription Factors in the Pathogenesis of Pediatric Rhabdomyosarcoma
  • Tissue Structure, Nuclear Organization, and Gene Expression in Normal and Malignant Breast
  • Laureate Citations
Show more Articles
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement